Patents by Inventor Souichi Oomizu

Souichi Oomizu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170010282
    Abstract: The object of the present invention is to provide a cell that can exhibit physiological activity based on galectin-9, a method for producing the cell, and use of the cell. In order to achieve the above object, the cell of the present invention contains galectin-9, and the galectin-9 is expressed on a cell surface.
    Type: Application
    Filed: July 22, 2016
    Publication date: January 12, 2017
    Inventors: Mitsuomi HIRASHIMA, Toshiro NIKI, Tomohiro ARIKAWA, Souichi OOMIZU, Takeshi KADOWAKI
  • Patent number: 9528089
    Abstract: The object of the present invention is to provide a cell that can exhibit physiological activity based on galectin-9, a method for producing the cell, and use of the cell. In order to achieve the above object, the cell of the present invention contains galectin-9, and the galectin-9 is expressed on a cell surface.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: December 27, 2016
    Assignee: GALPHARMA CO., LTD.
    Inventors: Mitsuomi Hirashima, Toshiro Niki, Tomohiro Arikawa, Souichi Oomizu, Takeshi Kadowaki
  • Patent number: 9493741
    Abstract: The object of the present invention is to provide a cell that can exhibit physiological activity based on galectin-9, a method for producing the cell, and use of the cell. In order to achieve the above object, the cell of the present invention contains galectin-9, and the galectin-9 is expressed on a cell surface.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: November 15, 2016
    Assignee: GALPHARMA CO., LTD.
    Inventors: Mitsuomi Hirashima, Toshiro Niki, Tomohiro Arikawa, Souichi Oomizu, Takeshi Kadowaki
  • Publication number: 20150093366
    Abstract: The object of the present invention is to provide a cell that can exhibit physiological activity based on galectin-9, a method for producing the cell, and use of the cell. In order to achieve the above object, the cell of the present invention contains galectin-9, and the galectin-9 is expressed on a cell surface.
    Type: Application
    Filed: September 29, 2014
    Publication date: April 2, 2015
    Inventors: Mitsuomi HIRASHIMA, Toshiro NIKI, Tomohiro ARIKAWA, Souichi OOMIZU, Takeshi KADOWAKI
  • Publication number: 20130323176
    Abstract: The object of the present invention is to provide a cell that can exhibit physiological activity based on galectin-9, a method for producing the cell, and use of the cell. In order to achieve the above object, the cell of the present invention contains galectin-9, and the galectin-9 is expressed on a cell surface.
    Type: Application
    Filed: December 9, 2011
    Publication date: December 5, 2013
    Inventors: Mitsuomi Hirashima, Toshiro Niki, Tomohiro Arikawa, Souichi Oomizu, Takeshi Kadowaki
  • Publication number: 20070148209
    Abstract: An agent for improving allergic predisposition is provided. This agent is effective in improving the allergic predisposition, safe, and readily ingestible. More specifically, an agent for improving allergic predisposition and an agent for suppressing production of IgE antibody containing a hydrolysate of water-soluble dietary fibers as its effective component are provided.
    Type: Application
    Filed: November 10, 2004
    Publication date: June 28, 2007
    Applicant: NISHIKAWA RUBBER CO., LTD.
    Inventors: Michihiro Hide, Yoshikazu Kameyoshi, Hidenori Suzuki, Souichi Oomizu